LABORATORIOS FARMACEUTICOS ROVI, S.A. «12345...» Page 1 out of 19 03/10/2024 09:05 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements Liquidity contract: transactions conducted in the third quarter of 2024 Register number: 30766 13/09/2024 11:27 LABORATORIOS FARMACEUTICOS ROVI, S.A. Total number of voting rights and capital The Company announces the registration in the Commercial Registry of the public deed of reduction of its share capital and the new share capital figure. Register number: 30489 12/09/2024 19:28 LABORATORIOS FARMACEUTICOS ROVI, S.A. Other relevant information The Company announces the registration in the Commercial Registry of the public deed of reduction of its share capital and the new share capital figure. Register number: 30484 01/08/2024 08:06 LABORATORIOS FARMACEUTICOS ROVI, S.A. Other relevant information The Company has agreed to execute the share capital reduction approved by the 2024 Ordinary General Meeting to amortize treasury shares, among which those acquired in the framework of the own shares repurchase program. Register number: 30108 31/07/2024 07:44 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements The Company informs about the modification of securities and cash balances associated with the Liquidity Contract signed between the Company and Bestinver, S.V., S.A. Register number: 30064 31/07/2024 07:28 LABORATORIOS FARMACEUTICOS ROVI, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del primer semestre de 2024 Register number: 30059 08/07/2024 10:24 LABORATORIOS FARMACEUTICOS ROVI, S.A. Other relevant information The Company informs about the dividends payment Register number: 29558 04/07/2024 10:23 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements Liquidity contract: transactions conducted in the second quarter of 2024 Register number: 29524 24/06/2024 14:01 LABORATORIOS FARMACEUTICOS ROVI, S.A. Announcement of general shareholders’ meeting The Company reports on the resolutions adopted by the Ordinary General Shareholders' Meeting and by the Board of Directors. Register number: 29281 11/06/2024 18:03 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes The Company informs about the completion of the Buy-back Programme, effective as of 26 July 2023, and the resumption of the Liquidity Contract, which was suspended when the Buy-back Programme commenced. Register number: 29094 Page 1 out of 19 «12345...»